Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy-Reference-Cited by-同舟云学术

Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy

Published:2024-05-23 Issue:6 Volume:25 Page:3685-3702
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Zhang Hao¹²,Xing Chengyuan²,Yan Binyuan¹,Lei Hanqi¹,Guan Yupeng¹²,Zhang Shiqiang¹,Kang Yang²^ORCID,Pang Jun¹^ORCID

Affiliation:

1. Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, P. R. China

2. Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, P. R. China

Funder

Sun Yat-sen University

Basic and Applied Basic Research Foundation of Guangdong Province

Sanming Project of Medicine in Shenzen Municipality

Science, Technology and Innovation Commission of Shenzhen Municipality

National Natural Science Foundation of China

Postdoctoral?Fellowship?Program?of?CPSF

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.4c00260

Reference67 articles.

1. Prostate cancer

2. Systemic treatments for high-risk localized prostate cancer

3. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

4. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

5. Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on Cytochrome P450 Metabolic Profile of Paclitaxel on Rats using QTOF-MS;Current Drug Metabolism;2024-07-19